These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 39018698)
21. Fabrication of folic acid-conjugated pyrimidine-2(5H)-thione-encapsulated curdlan gum-PEGamine nanoparticles for folate receptor targeting breast cancer cells. Kunjiappan S; Panneerselvam T; Pavadai P; Balakrishnan V; Pandian SRK; Palanisamy P; Sankaranarayanan M; Kabilan SJ; Sundaram GA; Tseng WL; Kumar ASK Int J Biol Macromol; 2024 Oct; 277(Pt 3):134406. PubMed ID: 39097067 [TBL] [Abstract][Full Text] [Related]
22. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells. Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875 [TBL] [Abstract][Full Text] [Related]
23. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications. Wang F; Yang S; Yuan J; Gao Q; Huang C J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869 [TBL] [Abstract][Full Text] [Related]
24. Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy. Mollarazi E; Jalilian AR; Johari-Daha F; Atyabi F J Labelled Comp Radiopharm; 2015 Jun; 58(8):327-35. PubMed ID: 26036233 [TBL] [Abstract][Full Text] [Related]
25. Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method. Zu Y; Zhao Q; Zhao X; Zu S; Meng L Int J Nanomedicine; 2011; 6():3429-41. PubMed ID: 22267927 [TBL] [Abstract][Full Text] [Related]
26. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409 [TBL] [Abstract][Full Text] [Related]
27. Folate-receptor-targeted laser-activable poly(lactide- Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177 [TBL] [Abstract][Full Text] [Related]
28. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery. Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924 [TBL] [Abstract][Full Text] [Related]
29. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells. Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396 [TBL] [Abstract][Full Text] [Related]
30. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel. Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815 [TBL] [Abstract][Full Text] [Related]
31. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery. Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136 [TBL] [Abstract][Full Text] [Related]
32. PLGA Nanoplatform for the Hypoxic Tumor Delivery: Folate Targeting, Therapy, and Ultrasound/Photoacoustic Imaging. Mehata AK; Bonlawar J; Tamang R; Malik AK; Setia A; Kumar S; Challa RR; Vallamkonda B; Koch B; Muthu MS ACS Appl Bio Mater; 2024 Aug; 7(8):5754-5770. PubMed ID: 39115968 [TBL] [Abstract][Full Text] [Related]
33. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951 [TBL] [Abstract][Full Text] [Related]
34. Targeted biocompatible Zn-metal-organic framework nanocomposites for intelligent chemotherapy of breast cancer cells. Fereydouni P; Al Mohaddesin A; Khaleghi S Sci Rep; 2024 Aug; 14(1):18311. PubMed ID: 39112669 [TBL] [Abstract][Full Text] [Related]
35. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells. Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392 [TBL] [Abstract][Full Text] [Related]
36. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo. Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490 [TBL] [Abstract][Full Text] [Related]
37. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Wang F; Wang Y; Ma Q; Cao Y; Yu B Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment. Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251 [TBL] [Abstract][Full Text] [Related]
39. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy. Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142 [TBL] [Abstract][Full Text] [Related]
40. Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging. Mehata AK; Singh V; Vikas ; Srivastava P; Koch B; Kumar M; Muthu MS Nanotheranostics; 2024; 8(2):179-201. PubMed ID: 38444739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]